When was Cybin founded?

Cybin was founded in 2002 and raised its 1st funding round 18 years after it was founded.

Where is Cybin located?

Cybin is headquartered in Toronto, Canada. It is registered at ONE SPENCER DOCK,NORTH WALL QUAY,DUBLIN,DUBLIN 1,DO1X9R7.

How many employees does Cybin have?

As of May 31, 2026, the latest employee count at Cybin is 97.

Is Cybin a funded company?

Cybin is a funded company, having raised an undisclosed amount across 7 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on May 05, 2020.

When was the latest funding round of Cybin?

Cybin's latest funding was a $***** Post IPO round on Jun 30, 2025, with participation from 0 investor.

Where does Cybin rank among its competitors?

Cybin ranks 4th amongst 31 active competitors, of which 10 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Psilera, which secured $8.8M in May, 2026.

Who are the top competitors of Cybin?

Cybin's top competitors include COMPASS Pathways, MindMed and Gilgamesh. Among them, Psilera secured the most recent funding round in May, 2026.

Cybin - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of psychedelic therapeutics for psychiatric disorders. The product pipeline includes CYB003 a deuterated psilocin for the adjunctive treatment of major depressive disorderCYB004 deuterated dimethyltryptamine compound targeting generalized anxiety disorder and CYB005 aphenethylamine derivative treating neuroinflammation.

Website: cybin.com
Email ID: *****@cybin.com
Registered Address: ONE SPENCER DOCK,NORTH WALL QUAY,DUBLIN,DUBLIN 1,DO1X9R7

Key Metrics

Founded Year

2002

Location

Toronto, Canada

Stage

Public

Latest Funding Round

Post IPO, Jun 30, 2025, $*****

Investors

Deep Track Capital & 11 more

Ranked

4^th among 31 active competitors

Employee Count

97 as on May 31, 2026

Investment & Acquisitions

Small Pharma & 1 more

Similar Companies

COMPASS Pathways & 37 more

Exit Details

Public

View Cybin's full profile

Cybin is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cybin Irl Limited CIN: FC039034 , United Kingdom, Active	Oct 18, 2021	-	-

Cybin got listed on Sep 13, 2019.

Click here to take a look at Cybin's IPO in detail

Cybin has raised funding over 7 rounds. Its first funding round was on May 05, 2020. Cybin has 12 institutional investors.

Here is the list of recent funding rounds of Cybin:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 30, 2025	3585799	Post IPO	2249167	1656167	1739665	9442734
Mar 19, 2024	7223421	Post IPO	3129366	5394773	1166786	Deep Track Capital
Mar 08, 2022	1527816	Post IPO	6216348	2450143	2930341	1577758

Access funding benchmarks and valuations. Sign up today!

View details of Cybin's funding rounds and investors

Cybin's employee count trend

Cybin has 97 employees as of May 26. Here is Cybin's employee count trend over the years:

Uncover Cybin's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cybin include COMPASS Pathways, MindMed and Gilgamesh. Here is the list of Top 10 competitors of Cybin, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	COMPASS Pathways 2016, London (United Kingdom), Public	Developer of therapies for treating mental disorders	$109M	Perceptive Advisors, Soleus Capital & 20 others	67/100
2nd	MindMed 2019, New York City (United States), Public	Developer of psychedelic-based therapies for brain health disorders	-	TR Ventures, DCVC & 9 others	58/100
3rd	Gilgamesh 2019, New York City (United States), Series B	Developer of drugs for neuropsychiatric conditions	$152M	Prime Movers Lab, Y Combinator & 18 others	57/100
4th	Cybin 2002, Toronto (Canada), Public	Provider of psychedelic therapeutics for psychiatric disorders	-	Deep Track Capital, LifeSci Venture Partners ... & 10 others	56/100
5th	Delix Therapeutics 2019, Menlo Park (United States), Series A	Developer of therapeutic solutions for the treatment of multiple neurological disorders	$100M	RA Capital Management, Artis Ventures & 22 others	55/100
6th	Neural Therapeutics 2020, Toronto (Canada), Public	Developer of ethnobotanical drug for neurological disorder	$495K	-	48/100
7th	Tryp Therapeutics 2020, Kelowna (Canada), Public	Developer of therapeutic solutions for treating neuropsychiatric disorders & pain	-	-	48/100
8th	Psilera 2019, Tampa (United States), Seed	Manufacturer of natural-based medicines for the treatment of mental health illnesses	$11.3M	Iter Investments, What If Ventures & 2 others	47/100
9th	Psyence 1997, Toronto (Canada), Public	Developer of psychedelic therapeutics for mental health disorders	-	-	47/100
10th	Eleusis 2013, London (United Kingdom), Acquired	Developer of immunomodulatory and neuroprotective medicines	$1.47M	Palo Santo, Noetic Psychedelic Fund & 4 others	46/100